Home / Resources / Articles (page 23)

Articles

The list of articles below are ordered by most recent. You will find articles here that are also listed in other categories. The list below is a catch-all for all articles on the site.

GLP-1s and Atrial Fibrillation: Do These Drugs Influence Cardiac Rhythm Risk?

GLP-1 medication pen on ECG chart with heart illustration showing atrial fibrillation and cardiac electrical activity

The relationship between GLP-1 therapies and atrial fibrillation is an emerging topic in diabetes care, raising an important question: could medications designed to protect the heart also influence its rhythm? Patients with diabetes already face a higher risk of atrial fibrillation, so understanding how these GLP-1 receptor agonists affect cardiac …

Read More »

GLP-1 Prescribing Without Baseline Data: Are We Skipping Critical Assessments?

Healthcare provider reviewing incomplete patient assessment form with GLP-1 injection pen and lab indicators in a clinical setting

A proper baseline assessment for GLP-1 therapy has become a critical yet sometimes overlooked step in modern diabetes care. In fast-moving clinical environments, especially with the rise of telehealth, providers may feel pressure to initiate GLP-1 therapy quickly. However, skipping essential baseline evaluations can lead to missed risks, poor outcomes, …

Read More »

Diabetes Without Clear Etiology: When Patients Don’t Fit Type 1 or Type 2

Doctor reviewing lab results and glucose data to assess atypical diabetes diagnosis in a clinical setting

What happens when a patient walks into your clinic and their diabetes simply doesn’t fit the usual mold? In many cases, clinicians rely on well-established categories like Type 1 or Type 2 diabetes. However, diagnosing atypical forms of diabetes is becoming increasingly important as more patients present with mixed or …

Read More »

GLP-1s and Peripheral Artery Disease: Can Metabolic Therapy Improve Limb Outcomes?

Close-up of lower leg with highlighted arteries showing peripheral artery disease and a GLP-1 injection pen held by a clinician

GLP-1 therapies are becoming an important focus in peripheral artery disease, especially as clinicians look beyond glucose control to improve outcomes in high-risk patients. People with diabetes and peripheral artery disease often face a difficult path, marked by poor circulation, delayed wound healing, and a higher risk of amputation. While …

Read More »

GLP-1 Therapy and Diagnostic Drift: Are We Masking Disease Progression?

GLP-1 injection pen with HbA1c test tubes and pancreas model illustrating hidden diabetes disease progression

Disease progression in patients using GLP-1 therapies is becoming a critical topic as these medications continue to reshape diabetes care. While GLP-1 receptor agonists improve glycemic control and support weight loss, could they also be hiding deeper metabolic decline? Much like a polished surface that conceals underlying cracks, improved lab …

Read More »

GLP-1 Use in Type 1 Diabetes: Where Adjunct Therapy May—and May Not—Make Sense

Medical setup showing insulin vial, GLP-1 injection pen, glucose meter, and pancreas model representing adjunct therapy in type 1 diabetes

GLP-1 receptor agonists as adjunct therapy in type 1 diabetes are gaining attention as clinicians look for new ways to improve glycemic control. But is this approach a promising tool or a risky shortcut? As emerging evidence builds, providers must balance potential benefits with safety concerns and patient-specific factors. Table …

Read More »

Who Is Managing GLP-1 Therapy Now? The Rise of Telehealth and Fragmented Diabetes Care

Doctor prescribing GLP-1 therapy via telehealth consultation with patient using digital devices

Telehealth prescribing of GLP-1 medications is rapidly reshaping how diabetes and weight management care is delivered. But as access expands, an important question emerges: who is truly managing patient care? Like a relay race without a clear handoff, patients often move between providers, platforms, and pharmacies without consistent oversight. As …

Read More »

GLP-1 Risk Stratification: Which Patients Are More Likely to Develop Side Effects?

Doctor explaining GLP-1 side effect risk factors to a patient using a visual chart with medication tools on a desk

The risk of side effects with GLP-1 therapies varies widely among patients, yet treatment decisions often overlook this variability. Why do some patients tolerate GLP-1 receptor agonists with ease while others discontinue early? Much like how individuals respond differently to diet or exercise, medication tolerance is influenced by a mix …

Read More »